Empiric therapy for pneumonia in the surgical intensive care unit

American Journal of Surgery

Volumn 179, Issue 2 SUPPL. 1, 2000, Pages 18-23

  Fabian, Timothy C ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; IMIPENEM; MACROLIDE; PENICILLIN G; QUINOLONE DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC THERAPY; ANTIBODY SPECIFICITY; BACTERIAL FLORA; BACTERICIDAL ACTIVITY; CELL KILLING; CONCENTRATION RESPONSE; CONFERENCE PAPER; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; PNEUMONIA; PRIORITY JOURNAL; SURGICAL PATIENT; VENTILATOR;

EID: 0034095383     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(00)00318-4     Document Type: Conference Paper

References (36)

1. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intens Care Med. 22:1996;387-394.
2. Luna C.M., Vujacich P., Niederman M.S., et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 111:1997;676-685.
3. Torres A., Aznar R., Gatell J.M., et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 142:1990;523-528.
4. McEachern R., Campbell G.D. Jr. Hospital-acquired pneumonia epidemiology, etiology, and treatment . Infect Dis Clin North Am. 12:1998;761-779.
5. Craven D.E., Kunches L.M., Lichtenberg D.A., et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis. 133:1986;792-796.
6. Celis R., Torres A., Gatell J.M., et al. Nosocomial pneumonia a multivariate analysis of risk and prognosis . Chest. 93:1988;318-324.
7. Fink M.P., Snydman D.R., Niederman M.S., et al. Treatment of severe pneumonia in hospitalized patients results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin . Antimicrob Agents Chemother. 38:1994;547-557.
8. Naziri W., Cheadle W.G., Pietsch J.D., Appel S., Polk H.C. Jr. Pneumonia in the surgical intensive care unit immunologic keys to the silent epidemic . Ann Surg. 219:1994;632-642.
9. Polk H.C. Jr, Livingston D.H., Fry D.E., et al. Treatment of pneumonia in mechanically ventilated trauma patients results of a prospective trial . Arch Surg. 132:1997;1086-1092.
10. Croce M.A., Fabian T.C., Waddle-Smith L., et al. Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia a prospective study . Ann Surg. 227:1998;743-755.
11. Hospital-acquired pneumonia in adults diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies: a consensus statement . Am J Respir Crit Care Med. 153:1995;1711-1725.
12. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1997, issued May 1997; a report from the NNIS System. AJIC Am J Infect Control. 1997;25:477-487.
13. Archibald L., Phillips L., Monnet D., et al. Antimicrobial resistance in isolates from inpatients and outpatients in the United States increasing importance of the intensive care unit . Clin Infect Dis. 24:1997;211-215.
14. Bryce E.A., Smith J.A. Focused microbiological surveillance and gram-negative beta-lactamase-mediated resistance in an intensive care unit. Infect Control Hosp Epidemiol. 16:1995;331-334.
15. Stratton C.W., Ratner H., Johnston P.E., Schaffner W. Focused microbiologic surveillance by specific hospital unit practical application and clinical utility . Clin Ther. 15:(suppl A):1993;12-20.
16. Rodriguez J.L., Miller C.G., DeForge L.E., et al. Local production of interleukin-8 is associated with nosocomial pneumonia. J Trauma. 33:1992;74-82.
17. Kollef M.H., Von Harz B., Prentice D., et al. Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia. Chest. 112:1997;765-773.
18. Rello J., Ausina V., Ricart M., Castella J., Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest. 104:1993;1230-1235.
19. 2-antagonists for stress ulcer prophylaxis a meta-analysis on efficacy and pneumonia rate . Crit Care Med. 19:1991;942-949.
20. Fabian T.C., Boucher B.A., Croce M.A., et al. Pneumonia and stress ulceration in severely injured patients a prospective evaluation of the effects of stress ulcer prophylaxis . Arch Surg. 128:1993;185-192.
21. Huxley E.J., Viroslav J., Gray W.R., Pierce A.K. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med. 64:1978;564-568.
22. Kirton O.C., DeHaven B., Morgan J., Morejon O., Civetta J. A prospective, randomized comparison of an in-line heat moisture exchange filter and heated wire humidifiers rate of ventilator-associated early onset (community-acquired) or late-onset (hospital-acquired) pneumonia and incidence of endotracheal tube occlusion . Chest. 112:1997;1055-1059.
23. Torres A., Serra-Batlles J., Ros E., et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation the effect of body position . Ann Intern Med. 116:1992;540-543.
24. Vallés J., Artigas A., Rello J., et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med. 122:1995;179-186.
25. Mosdell D.M., Morris D.M., Voltura A., et al. Antibiotic treatment for surgical peritonitis. Ann Surg. 214:1991;543-549.
26. Fagon J.Y., Chastre J., Hance A.J., Domart Y., Trouillet J.L., Gibert C. Evaluation of clinical judgement in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest. 103:1993;543-553.
27. Croce M.A., Fabian T.C., Stewart R.M., et al. Empiric monotherapy versus combination therapy of nosocomial pneumonia in trauma patients. J Trauma. 35:1993;303-311.
28. Craig W. Pharmacodynamics of antimicrobial agents as a base for determining dosage regimens. Eur J Clin Microbiol Infect Dis. 12:1993;6-8.
29. Niederman M.S. An approach to empiric therapy of nosocomial pneumonia. Med Clin North Am. 78:1994;1123-1141.
30. LaForce F.M. Systemic antimicrobial therapy of nosocomial pneumonia monotherapy versus combination therapy . Eur J Clin Microbiol Infect Dis. 8:1989;61-68.
31. Stratton C. Fluoroquinolone antibiotics properties of the class and individual agents . Clin Ther. 14:1992;348-375.
32. Fagon J.Y., Chastre J., Hance A.J., et al. Nosocomial pneumonia in ventilated patients a cohort study evaluating attributable mortality and hospital stay . Am J Med. 94:1993;281-288.
33. Update Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997 . MMWR. 46:1997;813-814.
34. Chow J.W., Fine M.J., Shlaes D.M., et al. Enterobacter bacteremia clinical features and emergence of antibiotic resistance during therapy . Ann Intern Med. 115:1991;585-590.
35. Kollef M.H., Vlasnik J., Sharpless L., et al. Scheduled change of antibiotic classes a strategy to decrease the incidence of ventilator-associated pneumonia . Am J Respir Crit Care Med. 156:1997;1040-1048.
36. Bowton D.L. Nosocomial pneumonia in the ICU - year 2000 and beyond. Chest. 115:1999;28S-33S.